openPR Logo
Press release

AI vs Radiologists: can AI surpass doctors in reporting accuracy?

11-26-2019 04:55 PM CET | Health & Medicine

Press release from: Oxipit

Leaders In AI Medical Imaging

Leaders In AI Medical Imaging

A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics (CARING) found that nearly 80% of AI generated chest X-ray case reports were as accurate as produced by a radiology specialist. Furthermore, AI reports were more accurate in 5% of analyzed patient cases. The study was undertaken using Oxipit ChestEye AI imaging suite. The full study titled The full study titled “Judging the Accuracy and Clinical Validity of Deep Learning-Generated Test Reports” will be presented at the annual Radiological Society of North America conference in Chicago later this year.

The study led by Dr Vasanth Venugopal aimed to evaluate the accuracy and clinical validity of AI-generated reports of chest X-rays. Additional aim of the study was to identify elements of “hedging” - a practice of using inconclusive, defensive, non-committal diagnosis statements in order to hedge against mistakes or potential legal threats - in clinical reports.

A set of 297 retrospective chest X-ray images was used in the study. The images were analyzed by Oxipit ChestEye and AI generated reports compared to the ones produced by a radiologist. Final report comparison and diagnosis validation was conducted by a radiologist with 9 years of clinical experience.

In 236 (79%) cases, algorithm-generated reports were found to be as accurate as the radiologists' reports. In 16 (5%) cases, algorithm generated reports were found to be either more accurate or more clinically appropriate. In 18 (6%) cases, the algorithm made significant diagnostic errors and in 27 (9%) cases, the algorithm-generated reports were found to be clinically inappropriate or insufficient even though the significant findings were correctly identified and localised.

“Oxipit ChestEye was designed as a productivity and second-opinion tool to aid the work of radiologists. The evaluation that nearly 80% of preliminary reports generated by our software were clinically accurate to be deemed as final reports, and in 5% cases - even more accurate than the ones produced by a radiologist, is an inspiring validation of current capabilities of AI diagnostics” - notes Dr N. Ramanauskas.

In the words of Dr N. Ramanauskas, even two radiologists can have differing opinions over a particular X-ray report.

“Therefore aiming for 100% correlation to radiologist reports is unrealistic. However, with constant improvement of deep learning algorithms and innovations in medical imaging field, a radiologist working with the help of AI can help to reduce interpersonal subjectivity and greatly increase the quality of the reports while helping the radiologists become more efficient.” - notes Dr N. Ramanauskas.

Oxipit ChestEye imaging suite encompasses a fully automatic computer aided diagnosis (CAD) platform which supports 75 radiological findings, covering over 90% of radiological cases presented to radiologists on a daily basis. ChestEye produces a standardized preliminary text report that incorporates all the radiologically relevant information present in a chest X-ray image, speeding up case description and minimizing the risk of overlooked secondary findings. Internal platform trials showed 30% time saved per patient case and reduced error rate by up to 50%.

The study also found that preliminary reports produced by Oxipit ChestEye AI platform can reduce hedging and defensive reporting statements in radiologist reports, resulting in clearer more actionable diagnosis descriptions.

“Subjectivity is part of human nature. Sometimes radiologists might be fairly confident that there is no pathology in the analyzed case, but they choose to include inconclusive vague diagnosis statements to hedge against potential mistakes or legal threats. On the contrary, AI produces clear, unbiased reports that can help to reassure radiologist in their opinion. A combination of both produces clearer, actionable reports to make treatment decisions, as well as helps to avoid unnecessary procedures resulting from evasive and non-committal reports” - notes Oxipit’ Chief Medical Officer Dr Naglis Ramanauskas.

Oxipit
Saulėtekio al. 15, LT-10224 Vilnius
Lithuania
info@oxipit.ai

ABOUT CARING
CARING (Centre for Advanced Research in Imaging, Neuroscience and Genomics) is a research & development center focused on performing cutting-edge scientific and clinical research and helping radiology and genomics companies develop world-class clinically relevant products. CARING is a wing of Mahajan Imaging - a leading high-end medical imaging service provider in New Delhi, India. Research and development partners of Mahajan Imaging include Massachusetts Institute of Technology (MIT), All India Institute of Medical Sciences and Indian Institute of Technology (IIT).

ABOUT OXIPIT
Oxipit is a computer vision software startup specialized in medical imaging. With a team of award-winning data scientists and medical doctors, the company aims to introduce innovative Artificial Intelligence/Deep Learning breakthroughs to everyday clinical practice. Oxipit are the authors of CE certified multi-award winning ChestEye radiology imaging suite.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI vs Radiologists: can AI surpass doctors in reporting accuracy? here

News-ID: 1872452 • Views:

More Releases from Oxipit

Oxipit Partners With CARPL To Increase Global Reach Of AI Diagnostic Products
03-02-2023 | Health & Medicine
Oxipit
Oxipit Partners With CARPL To Increase Global Reach Of AI Diagnostic Products
At the European Congress of Radiology in Vienna Oxipit announced that its diagnostic AI solutions will be available on the CARPL platform. CARPL platform users will have access to the full Oxipit AI product portfolio: ChestLink for healthy patient report automation, Quality - for real-time quality assurance and ChestEye - for preliminary reports. The move further builds on Oxipit strategy to increase global reach of company's products. "CARPL is our
Oxipit Secures Brazilian ANVISA Clearance for ChestEye AI Suite
02-15-2023 | Health & Medicine
Oxipit
Oxipit Secures Brazilian ANVISA Clearance for ChestEye AI Suite
The regulatory approval paves the way for ChestEye deployments in the Brazilian market. The application is already cleared for use in Europe and Australia. The Brazilian Health Regulatory Agency's approval is one of Oxipit steps to increase global reach for company products. "With many future-focused healthcare organizations, LatAm market shows tremendous potential for healthcare AI applications. Oxipit products have already shown strong market traction in the region. The ANVISA certification
Oxipit Closes $4.9M Funding Round To Advance AI Autonomy in Medical Imaging
01-23-2023 | Health & Medicine
Oxipit
Oxipit Closes $4.9M Funding Round To Advance AI Autonomy in Medical Imaging
AI medical imaging company Oxipit closed a $4.9M funding round led by Taiwania Capital and Practica Capital. Angel investors also participated in this round. The funding will help Oxipit advance its development of autonomous AI medical imaging applications and support market expansion into new geographic regions, with particular focus on the United Kingdom. "2022 was a breakthrough year for the Oxipit team. In spring we introduced ChestLink - the first fully
Oxipit Introduces Quality Assurance for MSK, MG, and CT Modalities
11-21-2022 | Health & Medicine
Oxipit
Oxipit Introduces Quality Assurance for MSK, MG, and CT Modalities
AI medical imaging company Oxipit expanded its Quality product suite with quality assurance support for musculoskeletal X-rays, mammography images and lung CT scans. Previously supporting only chest X-rays, the upgraded Quality suite aims to answer all imaging department quality assurance needs with a single product. The updated Quality product will be showcased at RSNA 2022 annual meeting later this month. Oxipit Quality employs AI as the second reader for quality assurance.

All 5 Releases


More Releases for Imaging

Mobile Gamma Cameras Market 2018 -- 2028 | By Indication Type (Cardiac Imaging, …
Mobile gamma camera is a portable version of the stationary gamma or angler camera used for nuclear imaging. Nuclear imaging involves injecting a radio nucleotide in the body or organ under study and record the resulting redioactivity by scanning with a gamma camera. Nuclear imaging is performed owing to its better resolution and selectivity than non-nuclear imaging such as MRI and ultrasound. The mobile gamma camera types include single, dual and
Holographic Imaging Market Latest Technological Innovations on Holoxica, Zebra I …
Market Study Report Adds Global Holographic Imaging Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market. Emergence of 3D holographic imaging has revolutionized the medical imaging and surgery. The technology converts the given two dimensional MRI and CT scan imaging data into interactive virtual reality images. Using these images doctors
Holographic Imaging Market : Eminent Players – EON Reality, Holoxica, Zebra Im …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient
Holographic Imaging Market Eminent Players – EON Reality, Holoxica, Zebra Imag …
Holographic Imaging Market size is set to exceed USD 3 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing adoption of holographic imaging in medical education should drive the holographic imaging market size over the forecast years. Medical practitioners and students are widely using holographic techniques to effectively study the human body, since the technology provides surgeons with a detailed view of patient anatomy
Holographic Imaging Market Projections Reviewed On Holoxica, Zebra Imaging, Oviz …
The newly released research at Market Study Report titled “2017-2024 Global Holographic Imaging Consumption Market Report” provides data, information, brief analysis, company profiles, statistics for past years and forecasts for next few years. Holographic Imaging Market size is set to exceed USD 3 billion by 2024. U.S. holographic imaging market accounted for significant industry share with expectations to witness healthy growth over coming years. Increasing biomedical research initiatives in holographic image
Digital Imaging Market,Digital Imaging Industry, Global Digital Imaging Market,D …
Latest industry research report on: Global Digital Imaging Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report presents the worldwide Digital Imaging market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry